20998 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Growth hormone-releasing factor [GH-RF] (Somatoliberin)
INJECTABLE NUTRIENT SOLUTION
#2TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB
#3TREATMENT OF MILD TRAUMATIC BRAIN INJURY
#4GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS
#5COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES
#6METHODS FOR OBTAINING CARDIOMYOGENIC PRECURSOR CELLS
#7LOCAL DELIVERY OF GROWTH AND REPAIR PROMOTING COMPOUNDS FOR TREATING, REDUCING AND/OR PREVENTING STRESS URINARY INCONTINENCE AND FECAL INCONTINENCE
#8GROWTH HORMONE-RELEASING HORMONE PEPTIDES AND FORMULATIONS THEREOF
#9Treating Inflammatory Lung Disease
#10EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY
#11GHRH or analogues thereof for use in treatment of hepatic disease
#12Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide
#13KITS, REAGENTS AND METHODS FOR THE ASSESSMENT OF LIVER DISEASES
#14METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
#15METHODS, DEVICES, AND SYSTEMS FOR TREATING LENS PROTEIN AGGREGATION DISEASES
#16LOW-DOSE PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#17TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB
#18Method of treating an inflammatory disorder
#19PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#20Pharmaceutical compositions for delivery of peptide
#21GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS
#22Treating inflammatory lung disease
#23METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES
#24PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#25Use of GHRP-6 as late cardioprotective and cardiac restoration medicament
#26GHRH or analogues thereof for use in treatment of hepatic disease
#27Manufacture of degarelix
#28Manufacture of Degarelix
#29Injectable presentations, syringes and compositions with sustained and/or controlled release of lanreotide
#30GHRH or analogues thereof for use in treatment of hepatic disease
#31METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE
#32Use of a growth hormone secretagogue peptide as a vaccine adjuvant
#33Composition and Methods for Stimulating Gastrointestinal Motility
#34GHRH or analogues thereof for use in treatment of hepatic disease
#35PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#36METHOD FOR TREATING MYELOID LEUKEMIA
#37METHODS OF TREATING MILD BRAIN INJURY
#38Methods for obtaining cardiomyogenic precursor cells
#39Sucrose acetate isobutyrate-based compositions, methods and uses thereof
#40Pharmaceutical compositions for delivery of peptide
#41Method of treating type I diabetes using an AAV vector encoding uracortin 2
#42Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#43Composition and Methods for Stimulating Gastrointestinal Motility
#44Manufacture of Degarelix
#45Pegylated bioactive peptides and uses thereof
#46Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#47POSTPRANDIAL GASTROKINETIC AGENT
#48Growth hormone releasing factor analogs and uses
#49METHODS OF TREATING COGNITIVE IMPAIRMENTS OR DYSFUNCTION
#50Method of treating type I diabetes using an AAV vector encoding uracortin 2
#51Ghrelin splice variant for treating neuronal damage, neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression
#52COMPOSITIONS AND METHODS FOR TREATING PITUITARY TUMORS
#53Manufacture of Degarelix
#54METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUE
#55Pegylated bioactive peptides and uses thereof
#56METHODS OF TREATING MILD BRAIN INJURY
#57Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#58Treatment of radiation injury using ghrelin
#59METHODS OF TREATING TRAUMATIC BRAIN INJURY
#60Stable formulations for parenteral injection of peptide drugs
#61Method for suppressing malignant tumor metastasis
#62Method of manufacture of GnRH-containing gel
#63Nanoencapsulation of hydrophilic active compounds
#64Method of drug formulation
#65Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
#66NOVEL N- AND C-TERMINAL SUBSTITUTED ANTAGONISTIC ANALOGS OF GH-RH
#67Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#68Postprandial gastrokinetic agent
#69Increasing drug affinity for crystalline microparticle surfaces
#70Medicinal agent for suppressing malignant tumor metastasis
#71Composition and methods for stimulating gastrointestinal motility
#72METHODS FOR TREATING CANCER WITH GHRH AGONISTS
#73Macrocyclic modulators of the ghrelin receptor
#74Manufacture of degarelix
#75Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease
#76USE OF UNACYLATED GHRELIN, FRAGMENTS AND ANALOGS THEREOF AS ANTIOXIDANT
#77Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
#78Protein Carrier-Linked Prodrugs
#79Microspheres for controlled- or sustained-release delivery of therapeutics
#80Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#81N- and C-terminal substituted antagonistic analogs of GH-RH
#82GHRH agonists for islet cell transplantation and function and the treatment of diabetes
#83GHRH agonists for the treatment of ischemic disorders
#84Stable formulations for parenteral injection of peptide drugs
#85Stable formulations for parenteral injection of peptide drugs
#86Stable formulations for parenteral injection of peptide drugs
#87Pharmaceutical composition and methods for peptide treatment
#88CARDIOPROTECTIVE EFFECTS OF GHRH AGONISTS
#89Method of treatment of small for gestational age infants under two years of age
#90ACCELERATION OF WOUND HEALING BY GROWTH HORMONE RELEASING HORMONE AND ITS AGONISTS
#91N- and C- terminal substituted antagonistic analogs of GH-RH
#92Macrocyclic modulators of the Ghrelin receptor
#93Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
#94Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#95Growth hormone secretatogue receptor antagonists and uses thereof
#96Pharmaceutical composition containing goserelin for in-situ implant
#97Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
#98Composition for nasal administration and method for preparing same
#99Therapeutic agent for accelerating recovery of animal under medical treatment
#100Medical compositions containing ghrelin
#101Pharmaceutical compositions for sustained release delivery of peptides
#102Stable formulations for parenteral injection of peptide drugs
#103Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator
#104Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
#105Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
#106Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
#107GH SECRETAGOGUES AND USES THEREOF
#108Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
#109Method for controlling fibrosis and other pathological deposits in tissues comprising administering a GHRP-6 composition
#110Compositions and methods for stimulating gastrointestinal motility
#111COMPOSITION FOR MUCOSAL ADMINISTRATION CONTAINING AGENT FOR ENHANCING MUCOSAL ABSORPTION OF PEPTIDE DRUG, AND ADMINISTRATION METHOD THEREOF
#112Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
#113UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE
#114TREATMENT AND PREVENTION OF DRY AGE-RELATED MACULAR DEGENERATION BY ACTIVATING CD36
#115MEASUREMENT OF G-PROTEIN mRNA IN THE DIAGNOSIS OF GROWTH HORMONE INSUFFICIENCY
#116SELECTION AND TREATMENT OF PATIENTS SUFFERING FROM WASTING
#117Liquid preparation of physiologically active peptide
#118Optimized high yield synthetic plasmids
#119Compositions comprising GHRH and GnRH and methods of using the same
#120NOVEL USES FOR 4-PHENYLBUTYRATE (4PBA) AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#121Renoprotection by growth hormone-releasing hormone and agonists
#122Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#123Ipamorelin Diacetate Injection and Infusion Solutions
#124Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#125USE OF CYTOCHROME P450-METABOLIZED DRUGS AND GRF MOLECULES IN COMBINATION THERAPY
#126USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY
#127Method of drug formulation of compositions comprising crystalline microparticle surfaces
#128Reproductive management
#129Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment
#130Ghrelin Protects Substantia Nigra Dopamine Neurons
#131Sustained release formulations comprising very low molecular weight polymers
#132USE OF GRF-1 (1-29 ) AND CORTICOTROPIN-RELEASING FACTOR AS THERAPEUTIC AGENTS
#133Compositions and methods for modulating ghrelin-mediated conditions
#134UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE TREATMENT OF METABOLIC DISORDERS
#135Antioxidant activity of GH-RH Antagonists
#136STABILIZED SUSPENSION
#137Methods for reducing the mitogenicity of lectin compositions
#138COMPOSITIONS FOR INCREASING BODY WEIGHT, USE AND METHODS
#139Neurotoxin therapy for postprandial hyperglycemia
#140TREAMENT FOR CHEMICAL SUBSTANCE ADDICTION
#141Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage
#142GH secretagogues and uses thereof
#143Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
#144Growth hormone releasing hormone treatment to decrease cholesterol levels
#145Pharmaceutical compositions and methods for peptide treatment
#146Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient
#147Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
#148Compositions and methods for stimulating gastrointestinal motility
#149COMPOSITION AND METHOD TO ALTER LEAN BODY MASS AND BONE PROPERTIES IN A SUBJECT
#150GH secretagogues and uses thereof
#151PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 TO PREVENT AND ELIMINATE FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUES
#152Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient
#153Gene therapy expression of GHRH for increasing RBC count in subjects
#154Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
#155Methods for treating obesity and obesity related diseases and disorders
#156Treatment of sepsis and septic shock using ghrelin and growth hormone
#157GH SECRETAGOGUES AND USES THEREOF
#158GHRH ANALOGS AND THERAPEUTIC USES THEREOF
#159Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
#160GH secretagogues and uses thereof
#161REDUCING CULLING IN HERD ANIMALS GROWTH HORMONE RELEASING HORMONE (GHRH)
#162Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
#163Growth-Hormone Secretagogues
#164Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance
#165PHARMACEUTICAL FORMULATIONS OF GHRH MOLECULES
#166Treatment of Inclusion Body Myositis
#167Liquid Preparation of Physiologically Active Peptide
#168Use Of Secretagogue For The Teatment Of Ghrelin Deficiency
#169Use of growth hormone releasing factor analogs in treating patients suffering from wasting
#170Medical compositions containing ghrelin
#171Pharmaceutical compositions for sustained release delivery of peptides
#172TREATMENT OF HIV-ASSOCIATED DYSMORPHIA/DYSMETABOLIC SYNDROME (HADDS) WITH OR WITHOUT LIPODYSTROPHY
#173Pharmaceutical compositions and methods for peptide treatment
#174Preventives or remedies for hepatopathy
#175GRF-containing lyophilized pharmaceutical compositions
#176Reproductive management
#177Methods for reducing the mitogenicity of lectin compositions
#178Polymer-drug conjugates
#179Growth hormone secretagogue receptor type 1A agonists
#180Compositions and methods for treatment of muscle pain and muscle wasting
#181Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
#182Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
#183Mammalian obestatin receptors
#184Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
#185Compositions and methods for modulating body weight and treating obesity-related disorders
#186Remedy for diabetes
#187Liquid growth hormone formulation and process of preparation thereof
#188Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
#189Method of stimulating growth and resistance to diseases of aquatic organisms
#190Use of ghrelin for treating malnutrition in gastrectomized individuals
#191Optimized high yield synthetic plasmids
#192Therapeutic peptide formulations with improved stability
#193PEPTIDE PHARMACEUTICAL FORMULATIONS
#194Medical compositions containing ghrelin
#195GRF-containing lyophilized pharmaceutical compositions
#196Oral drug delivery compositions and methods
#197Use of GnRH agonists to support the luteal phase during infertility treatment
#198Low molecular weight peptidomimetic growth hormone secretagogues
#199Identification and use of growth hormone secretagogue receptor type 1A antagonists
#200Lactone bearing absorbable polymers
#201Active agent transport systems
#202Pharmaceutical compositions and methods for peptide treatment
#203Method for selectively inhibiting ghrelin action
#204GH secretagogues and uses thereof
#205Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation
#206Delivery system for growth hormone releasing peptides
#207Sustained release drug formulations containing a carrier peptide
#208Composition and apparatus for transdermal delivery
#209Compositions and methods for treating ileus
#210Cell migration inhibitor
#211Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy